AU2022310347A1 - Bicyclic peptide inhibitors of interleukin-23 receptor - Google Patents
Bicyclic peptide inhibitors of interleukin-23 receptor Download PDFInfo
- Publication number
- AU2022310347A1 AU2022310347A1 AU2022310347A AU2022310347A AU2022310347A1 AU 2022310347 A1 AU2022310347 A1 AU 2022310347A1 AU 2022310347 A AU2022310347 A AU 2022310347A AU 2022310347 A AU2022310347 A AU 2022310347A AU 2022310347 A1 AU2022310347 A1 AU 2022310347A1
- Authority
- AU
- Australia
- Prior art keywords
- alkyl
- phe
- cyano
- substituted
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163221854P | 2021-07-14 | 2021-07-14 | |
| US63/221,854 | 2021-07-14 | ||
| PCT/US2022/037202 WO2023288017A2 (en) | 2021-07-14 | 2022-07-14 | Bicyclic peptide inhibitors of interleukin-23 receptor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2022310347A1 true AU2022310347A1 (en) | 2024-02-29 |
Family
ID=84920518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2022310347A Pending AU2022310347A1 (en) | 2021-07-14 | 2022-07-14 | Bicyclic peptide inhibitors of interleukin-23 receptor |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240352073A1 (https=) |
| EP (1) | EP4370532A4 (https=) |
| JP (1) | JP2024525723A (https=) |
| KR (1) | KR20240034223A (https=) |
| CN (1) | CN117980320A (https=) |
| AR (1) | AR126457A1 (https=) |
| AU (1) | AU2022310347A1 (https=) |
| CA (1) | CA3226492A1 (https=) |
| MX (1) | MX2024000761A (https=) |
| TW (1) | TW202321275A (https=) |
| UY (1) | UY39858A (https=) |
| WO (1) | WO2023288017A2 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4091624A1 (en) | 2013-03-15 | 2022-11-23 | Protagonist Therapeutics, Inc. | Hepcidin analogues and uses thereof |
| HRP20211448T1 (hr) | 2014-05-16 | 2021-12-24 | Protagonist Therapeutics, Inc. | Alfa4beta7 integrin tioeter peptidni antagonisti |
| CN107206254B (zh) | 2014-07-17 | 2021-08-24 | 领导医疗有限公司 | 白细胞介素-23受体的口服肽抑制剂以及其治疗炎症性肠病的用途 |
| CA3089868A1 (en) | 2018-02-08 | 2019-08-15 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| AU2021209086A1 (en) | 2020-01-15 | 2022-08-04 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| JP7397239B2 (ja) | 2020-11-20 | 2023-12-12 | ヤンセン ファーマシューティカ エヌ．ベー． | インターロイキン－２３受容体のペプチド阻害剤の組成物 |
| EP4370146A4 (en) | 2021-07-14 | 2025-05-21 | Janssen Biotech, Inc. | Lipidated peptide inhibitors of the interleukin-23 receptor |
| WO2024155551A1 (en) * | 2023-01-16 | 2024-07-25 | Janssen Pharmaceutica Nv | Polycyclic peptide inhibitors of interleukin-23 receptor |
| EP4471049A1 (en) | 2023-06-01 | 2024-12-04 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| EP4471048A1 (en) | 2023-06-01 | 2024-12-04 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| CN121909205A (zh) | 2023-09-08 | 2026-04-21 | 赛诺菲 | 作为选择性il-23受体抑制剂的新型肽 |
| CN121794283A (zh) | 2023-09-08 | 2026-04-03 | 赛诺菲 | 作为选择性il-23受体抑制剂的新型肽 |
| WO2025076414A1 (en) * | 2023-10-06 | 2025-04-10 | The Children's Medical Center Corporation | Compositions and methods for selecting a subject for inflammatory bowel disease treatment |
| WO2026013260A1 (en) | 2024-07-12 | 2026-01-15 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| WO2026041110A1 (zh) * | 2024-08-22 | 2026-02-26 | 上海瀚辰星泰医药科技有限公司 | 一种多肽化合物及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107206254B (zh) * | 2014-07-17 | 2021-08-24 | 领导医疗有限公司 | 白细胞介素-23受体的口服肽抑制剂以及其治疗炎症性肠病的用途 |
| US10301371B2 (en) * | 2014-10-01 | 2019-05-28 | Protagonist Therapeutics, Inc. | Cyclic monomer and dimer peptides having integrin antagonist activity |
| MX384213B (es) * | 2015-07-15 | 2025-03-14 | Protagonist Therapeutics Inc | Inhibidores peptidicos del receptor de interleucina 23 y su uso para tratar enfermedades inflamatorias. |
| JP7100034B2 (ja) * | 2016-12-06 | 2022-07-12 | シュティヒティング・ヴォール・デ・テクニシェ・ヴェテンシャッペン | 多環式ペプチド及びそれらの調製方法 |
| WO2019034866A1 (en) * | 2017-08-14 | 2019-02-21 | Bicyclerd Limited | BICYCLIC PEPTIDE LIGANDS CONJUGATES AND USES THEREOF |
| CN111712509A (zh) * | 2017-12-15 | 2020-09-25 | 詹森生物科技公司 | 作为sting激动剂的环状二核苷酸 |
| WO2020014646A1 (en) * | 2018-07-12 | 2020-01-16 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| WO2021007433A1 (en) * | 2019-07-10 | 2021-01-14 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
-
2022
- 2022-07-14 EP EP22842895.9A patent/EP4370532A4/en active Pending
- 2022-07-14 CN CN202280062001.1A patent/CN117980320A/zh active Pending
- 2022-07-14 US US18/579,033 patent/US20240352073A1/en active Pending
- 2022-07-14 CA CA3226492A patent/CA3226492A1/en active Pending
- 2022-07-14 TW TW111126553A patent/TW202321275A/zh unknown
- 2022-07-14 MX MX2024000761A patent/MX2024000761A/es unknown
- 2022-07-14 WO PCT/US2022/037202 patent/WO2023288017A2/en not_active Ceased
- 2022-07-14 UY UY0001039858A patent/UY39858A/es unknown
- 2022-07-14 JP JP2024501737A patent/JP2024525723A/ja active Pending
- 2022-07-14 AR ARP220101855A patent/AR126457A1/es unknown
- 2022-07-14 AU AU2022310347A patent/AU2022310347A1/en active Pending
- 2022-07-14 KR KR1020247004796A patent/KR20240034223A/ko active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024525723A (ja) | 2024-07-12 |
| UY39858A (es) | 2023-02-28 |
| KR20240034223A (ko) | 2024-03-13 |
| CA3226492A1 (en) | 2023-01-19 |
| EP4370532A2 (en) | 2024-05-22 |
| WO2023288017A3 (en) | 2023-03-09 |
| WO2023288017A2 (en) | 2023-01-19 |
| TW202321275A (zh) | 2023-06-01 |
| US20240352073A1 (en) | 2024-10-24 |
| MX2024000761A (es) | 2024-04-18 |
| CN117980320A (zh) | 2024-05-03 |
| EP4370532A4 (en) | 2025-09-03 |
| AR126457A1 (es) | 2023-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2022310347A1 (en) | Bicyclic peptide inhibitors of interleukin-23 receptor | |
| EP4370531A2 (en) | Peptide inhibitors of interleukin-23 receptor | |
| JP7441955B2 (ja) | インターロイキン２３受容体のペプチド阻害剤および炎症性疾患を治療するためのその使用 | |
| WO2023288019A2 (en) | Lipidated peptide inhibitors of interleukin-23 receptor | |
| JP7670605B2 (ja) | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのその使用 | |
| JP2025134806A (ja) | インターロイキン２３受容体のペプチド阻害剤及び炎症性疾患を治療するためのその使用 | |
| WO2021007433A1 (en) | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | |
| JP2022540154A (ja) | インターロイキン－２３受容体のペプチド阻害剤及び炎症性疾患を治療するためのその使用 | |
| WO2021146458A1 (en) | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | |
| AU2024210741A1 (en) | Peptide inhibitors of interleukin-23 receptor | |
| HK40111925A (zh) | 白介素-23受体的脂化肽抑制剂 | |
| HK40083331A (en) | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | |
| EA049310B1 (ru) | Пептидные ингибиторы рецептора интерлейкина-23 и их применение для лечения воспалительных заболеваний |